Tectonic Therapeutic TECX
NASDAQ TECX
$30.75 +0.83 (+2.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2026)

Tectonic Therapeutic (TECX) posted quarterly Retained Earnings of $474.2 million for Q4 2025, up 5268344.44% year-over-year from N/an in Q4 2024, and up 333.0% quarter-over-quarter from -$203.5 million in Q3 2025.

Analysis

Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2026) Analysis & Trends

Tectonic Therapeutic (TECX) has reported Retained Earnings for 9 consecutive years, with $474.2 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Retained Earnings rose 5268344.44% year-over-year to $474.2 million; the TTM figure through Dec 2025 stood at $474.2 million (up 5268344.44% YoY), while the FY2025 annual figure was $474.2 million, up 5268344.44% from the prior year.
  • Retained Earnings climbed to $474.2 million in Q4 2025 per TECX's latest filing, from -$203.5 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $474.2 million in Q4 2025 and bottomed at -$514.4 million in Q1 2023.
  • Historically, Retained Earnings has averaged -$243.1 million across 5 years, with a median of -$339.0 million in 2021.
  • On a YoY basis, Retained Earnings climbed as much as 5268344.44% in 2025 and fell as far as 264185.71% in 2025.
  • Tectonic Therapeutic's Retained Earnings stood at -$383.5 million in 2021, then declined by 27.61% to -$489.4 million in 2022, then jumped by 101.22% to $6.0 million in 2023, then tumbled by 99.85% to $9000.0 in 2024, then jumped by 5268344.44% to $474.2 million in 2025.
  • Business Quant data shows TECX's Retained Earnings at $474.2 million in Q4 2025, -$203.5 million in Q3 2025, and -$184.5 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Tectonic Therapeutic 589.02 Mn 589.02 Mn - 494.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 494.11 Mn
Mar 31, 2026 478.39 Mn
Dec 31, 2025 474.16 Mn
Sep 30, 2025 471.11 Mn
Jun 30, 2025 468.29 Mn
Mar 31, 2025 465.52 Mn
Dec 31, 2024 289.35 Mn
Sep 30, 2024 286.65 Mn
Jun 30, 2024 284.92 Mn
Mar 31, 2024 -484.08 Mn
Dec 31, 2023 -90.60 Mn
Sep 30, 2023 -468.49 Mn
Jun 30, 2023 -446.91 Mn
Mar 31, 2023 -514.39 Mn
Dec 31, 2022 -489.43 Mn
Sep 30, 2022 -464.40 Mn
Jun 30, 2022 -441.43 Mn
Mar 31, 2022 -413.38 Mn
Dec 31, 2021 -383.54 Mn
Sep 30, 2021 -355.32 Mn